Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101704
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101704
Table 1 Clinical characteristics of the patients with metabolic dysfunction-associated steatotic liver disease by group
Parameter
Group A, n = 25
Group B, n = 25
P value
Sex0.333
    Male5 (20)8 (32)
    Female20 (80)17 (68)
Age in years54.7 + 10.554.3 + 11.50.229
Weight82.2 + 16.482.1 + 14.20.473
BMI32.8 + 6.933.3 + 4.70.394
    Normal weight--
    Overweight10 (40)5 (20)
    Obesity I5 (20)10 (40)
    Obesity II6 (24)9 (36)
    Obesity III4 (16)1 (4)
Comorbidities
    Diabetes6 (24)6 (24)0.629
    High blood pressure7 (28)8 (32)0.758
    Hypercholesterolemia8 (32)5 (20)0.333
    Hypertriglyceridemia6 (24)4 (16)0.480
    Hypothyroidism2 (8)2 (8)0.695
    Others--